---
figid: PMC11720236__ijms-26-00343-g004
figtitle: Exercise modulation of myocardial fibrosis
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11720236
filename: ijms-26-00343-g004.jpg
figlink: /pmc/articles/PMC11720236/figure/F4/
number: F4
caption: 'Mechanisms of exercise modulation of myocardial fibrosis. Aging, myocardial
  infarction, metabolic diseases, and hypertension can all lead to myocardial fibrosis.
  Aging: Exercise reduces collagen deposition by enhancing MMP-2 activity and decreasing
  the expression of fibrosis-associated factors (TGF-β1, TIMP-1, COL-I). It also restores
  endogenous H2S levels or inhibits the FGF-2/uPA/MMP-2 signaling pathway. Metabolic
  diseases: Exercise inhibits the TGF-β1/Smad signaling pathway or reduces ROS production,
  promoting HO-1 expression and inhibiting fibrosis-related factors. Myocardial infarction:
  Exercise inhibits TGF-β1 signaling through the NRG-1/ErbB signaling pathway or by
  upregulating miR-29a, miR-101a, and FGF-21 expression. In addition, exercise can
  also secrete several myokines such as irisin, CHI3L1, and FSTL1 to ameliorate myocardial
  fibrosis after myocardial infarction. Hypertension: Exercise attenuates myocardial
  fibrosis by inhibiting the LOXL-2/TGF-β signaling pathway and the expression of
  AT1R and FGF23, or by promoting the expression of ccdc80tide and AMPKα1. MMP: matrix
  metallopeptidase; TGF-β1: transforming growth factor-β1; TIMP-1: tissue inhibitor
  of metal protease1; H2S: hydrogen sulfide; COL-Ⅰ: Collagen 1; FGF-2: fibroblast
  growth factor 2; uPA: urokinase-type plasminogen activator; NRG1: Neuregulin 1;
  FGF-21: fibroblast Growth Factor 21; miR-29a: microRNA-29a; miR-101a: microRNA-101a;
  smad: small mother decapentaplegic protein; ROS: reactive oxygen species; CTGF:
  connective tissue growth factor; HO-1: heme oxygenase 1; JAK: janus kinase 2; STAT3:
  signal transducer and activator of transcription 3; AMPKα1: AMP-activated protein
  kinase α1; Sirt1: silent information regulator 1; PGC-1α: peroxisome proliferator-activated
  receptor gamma coactivator 1-α; AT1R: Ang II-angiotensin II type I receptor; FGF-23:
  fibroblast Growth Factor 23; LOXL2: Lysyl oxidase-like 2; miR-34a: microRNA-34a;
  miR-486a-5p: microRNA-486a-5p; miR-29: microRNA-29; miR-133: microRNA-133; TNF-α:
  tumor necrosis factor; NF-kB: nuclear factor kappa-B; AKT: protein kinase B; PI3K:
  phosphoinositide 3-kinase; ALCAT1: lysocardiolipin acyltransferase-1. Created with
  Figdraw (www.figdraw.com), license ID: PRPRW1c841'
papertitle: 'Physical Exercise: A Promising Treatment Against Organ Fibrosis'
reftext: Xiaojie Ma, et al. Int J Mol Sci. 2025 Jan;26(1).
year: '2025'
doi: 10.3390/ijms26010343
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: fibrosis | exercise | therapeutics | mechanism
automl_pathway: 0.9544621
figid_alias: PMC11720236__F4
figtype: Figure
redirect_from: /figures/PMC11720236__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11720236__ijms-26-00343-g004.html
  '@type': Dataset
  description: 'Mechanisms of exercise modulation of myocardial fibrosis. Aging, myocardial
    infarction, metabolic diseases, and hypertension can all lead to myocardial fibrosis.
    Aging: Exercise reduces collagen deposition by enhancing MMP-2 activity and decreasing
    the expression of fibrosis-associated factors (TGF-β1, TIMP-1, COL-I). It also
    restores endogenous H2S levels or inhibits the FGF-2/uPA/MMP-2 signaling pathway.
    Metabolic diseases: Exercise inhibits the TGF-β1/Smad signaling pathway or reduces
    ROS production, promoting HO-1 expression and inhibiting fibrosis-related factors.
    Myocardial infarction: Exercise inhibits TGF-β1 signaling through the NRG-1/ErbB
    signaling pathway or by upregulating miR-29a, miR-101a, and FGF-21 expression.
    In addition, exercise can also secrete several myokines such as irisin, CHI3L1,
    and FSTL1 to ameliorate myocardial fibrosis after myocardial infarction. Hypertension:
    Exercise attenuates myocardial fibrosis by inhibiting the LOXL-2/TGF-β signaling
    pathway and the expression of AT1R and FGF23, or by promoting the expression of
    ccdc80tide and AMPKα1. MMP: matrix metallopeptidase; TGF-β1: transforming growth
    factor-β1; TIMP-1: tissue inhibitor of metal protease1; H2S: hydrogen sulfide;
    COL-Ⅰ: Collagen 1; FGF-2: fibroblast growth factor 2; uPA: urokinase-type plasminogen
    activator; NRG1: Neuregulin 1; FGF-21: fibroblast Growth Factor 21; miR-29a: microRNA-29a;
    miR-101a: microRNA-101a; smad: small mother decapentaplegic protein; ROS: reactive
    oxygen species; CTGF: connective tissue growth factor; HO-1: heme oxygenase 1;
    JAK: janus kinase 2; STAT3: signal transducer and activator of transcription 3;
    AMPKα1: AMP-activated protein kinase α1; Sirt1: silent information regulator 1;
    PGC-1α: peroxisome proliferator-activated receptor gamma coactivator 1-α; AT1R:
    Ang II-angiotensin II type I receptor; FGF-23: fibroblast Growth Factor 23; LOXL2:
    Lysyl oxidase-like 2; miR-34a: microRNA-34a; miR-486a-5p: microRNA-486a-5p; miR-29:
    microRNA-29; miR-133: microRNA-133; TNF-α: tumor necrosis factor; NF-kB: nuclear
    factor kappa-B; AKT: protein kinase B; PI3K: phosphoinositide 3-kinase; ALCAT1:
    lysocardiolipin acyltransferase-1. Created with Figdraw (www.figdraw.com), license
    ID: PRPRW1c841'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MMP2
  - TIMP1
  - COL1A1
  - COL1A2
  - TGFB1
  - FGF21
  - MIR29A
  - FOS
  - FOSB
  - FOSL1
  - FOSL2
  - PLAU
  - PRAP1
  - FGF2
  - SIRT1
  - CHI3L1
  - NRG1
  - FSTL1
  - PPARGC1A
  - FNDC5
  - LCLAT1
  - AGTR1
  - EGFR
  - ERBB2
  - ERBB3
  - ERBB4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - SMAD2
  - SMAD3
  - TNF
  - SIRT3
  - TGFB2
  - TGFB3
  - AKT1
  - AKT2
  - AKT3
  - MMP9
  - NFKB1
  - CCN2
  - MIR34A
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - PRKAA1
  - HMOX1
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - STAT3
  - FGF23
  - LOXL2
  - H2S
  - NRG1
  - TNF-a
  - Sex hormones
  - ROS
  - Hypertension
  - Myocardial infarction
---
